The Australasian Professional Society on Alcohol and other Drugs

News & Media

Webinar: ClinTrial Refer: A New APProach to Increasing Cross-Referral and Recruitment to Clinical Trials

WEBINAR

clintrial refer app logoClinTrial Refer: A New APProach to Increasing Cross-Referral and Recruitment to Clinical Trials

When: 13.00 (AEST) Thursday 16 July

Presenter: Mrs Christine Zahren, Business Development Manager, ClinTrial Refer

Clinical Trial Refer (CTR), a mobile app and website platform, that helps connect patients and clinicians to current clinical trials, facilitating the connection of individuals to studies with interventions that may help them.

The NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN) invested in the CTR app to enable Addiction Medicine clinicians to enhance client access to clinical trials. Learn how to connect your patients to relevant trials via the CTR app.

REGISTER FOR THIS WEBINAR

Register in advance for this webinar. After registering, you will receive a confirmation email containing information about joining the webinar.

 

APSAD Student Membership is now FREE

Access member-only benefits and resources without barriers

APSAD understands the difficulty students face around limited funding and the need to have a support network and recognise that students are the future of the alcohol and other drug sector. Providing free membership allows students studying in Australia and New Zealand to access member-only benefits and resources without barriers.

Student members have access to exclusive Early to Mid Career Researchers (EMCR) events, networking, mentoring, advice and guidance, supporting our Student Members, through a range of membership activities and benefits.

Help spread the word amongst your networks, information on how to apply and eligibility for student membership can be found on our membership page. https://www.apsad.org.au/membership/categories

 

ECR4

 

ASCP Webinars: July - September Webinar Details

ASCP banner

12.00 (AEST) Tuesday 28 July 2020 l  Add to Calendar

The Utilisation, Effectiveness & Safety of Smoking Cessation Pharmacotherapies During Pregnancy: An Australian Population-Based Study

Presenter: Alys Havard, Senior Research Fellow, Centre for Big Data Research in Health, University of NSW

This NHMRC-funded research used linked pharmaceutical claims and administrative health data for all women who gave birth in New South Wales and Western Australia between 2004 and 2012 to examine the extent to which prescription NRT patches, bupropion and varenicline are used during pregnancy. To examine the effectiveness of these medicines during pregnancy, the smoking cessation rates associated with varenicline relative to NRT patch use was measured. The risk and benefits associated with these medicines in pregnancy was assessed by comparing the rate of adverse birth outcomes among women who used prescription NRT patches, bupropion or varenicline with the rate among women who smoked but did not receive any of these medicines.

Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_GAWMPIT2S2C-6I7rRhH_3Q

After registering, you will receive a confirmation email containing information about joining the webinar.

--------------------------------------------------------

12.00 (AEST) Tuesday 25 August 2020 l Add to Calendar

An Evaluation of Online and Automated Smoking Cessation Programs

Presenter: Prof Ron Borland, Deputy Director, Melbourne Centre for Behaviour Change, School of Psychological Sciences, University of Melbourne

There is now a plethora of online smoking cessation apps and programs, most completely unevaluated and often not based on strong theoretical principles. This presentation will focus on what works and which might be available to Australian smokers. In particular, I will describe the characteristics of the QuitCoach (which I developed), the strong evidence base behind it, and the key techniques that appear to be behind its effectiveness. I will also discuss how automated resources might be used as complements to person-delivered resources, especially for smokers with more than average needs for help.

Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_1YvBa5wPT06pIfRSkreqkA

After registering, you will receive a confirmation email containing information about joining the webinar.

--------------------------------------------------------

12.00 (AEST) Tuesday 29 September 2020 l Add to Calendar

ASCP Webinar: Smoke screen: A novel approach to promoting smoke free pregnancy

Presenter: Nancy Westcott, Manager Statewide Smoking Cessation Program, Alcohol and Drug Service, Tasmanian Health Service

A Quality Improvement Activity undertaken by the Smoking Cessation Program at the Royal Hobart Hospital that involved carbon monoxide monitoring, demonstrated an eight-fold increase in referral of pregnant women to cessation services. This enabled funding to be secured for an ethics approved, one-year pilot project (the first of its kind in Australia) to explore the effectiveness on an opt-out routine CO monitoring model within a Midwifery Group Practice cohort of 500 women. Tune in to hear how it all about it!

Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_IHBDKTMORDCD-i0X2zMIGg

After registering, you will receive a confirmation email containing information about joining the webinar.

 

 

ASCP Webinar: Smoking and the Course of COVID: Clear or Mud?

ASCP banner

12.00 (AEST) Tuesday 30 June 2020 

ASCP Webinar: Smoking and the Course of COVID – Clear or Mud?

Presenter: Professor Matther Peters AM, Respiratory Physician and Head of Respiratory Medicine at Concord Hospital

Details of the presentation will be provided shortly.

Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_eyzzzHjeRuCJ469pgbxvXg

After registering, you will receive a confirmation email containing information about joining the webinar

 

APSAD General Meeting

Notice of General Meeting

APSAD Council is calling a General Meeting of members on Monday 22nd June at 12.30 to be held via zoom to propose a Special Resolution for an amendment to the Society's Constitution to allow for the key positions of President, Vice President/President Elect and Treasurer to remain on Council for longer than is currently allowed within the Constitution.

Attendance from members would be greatly appreciated so that we are able to pass the resolution. If you are unable to attend you can appoint a proxy (details and proxy form below) to attend and vote on your behalf. 

To view the section in question download a copy of the Society's Constitution, head to page 29 Item 54. Term of Office

Notice is hereby given that a General Meeting of the Australasian Professional Society on Alcohol and Other Drugs (APSAD) will be held as follows:

on:  Monday 22nd June 2020

at:   Online via ZoomPlease register in advance to attend the General Meeting

commencing at: 12.30pm (the General Meeting will run for approx 30 minutes)

for the purpose of transacting the following items of business:

If you are unable to attend the General Meeting you may appoint one person to attend and vote at the meeting as your proxy. Proxies may only be appointed by returning the Proxy Form via email to This email address is being protected from spambots. You need JavaScript enabled to view it. by 17:00 Friday 19th June.

You may appoint the Chairman as your proxy or your own proxy. A proxy need not be a member. The Proxy Form must be signed by the member or an attorney duly authorised in writing.

If you have any questions regarding the General Meeting, appointing a proxy, or you would like a Word version of the proxy form, email Liz Baxter at This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Webinar: Smoking cessation care for pregnant and postpartum Indigenous Australian women: A collective approach

ASCP banner

The monthly ASCP webinars have returned, our first webinar is next Tuesday.

12.30 (AEST) Tuesday 26 May 2020  Add to Calendar

Smoking cessation care for pregnant and postpartum Indigenous Australian women: A collective approach

Effective smoking cessation care (SCC) can save unnecessary loss of lives and smoking-related life long morbidity. The urgency of quitting smoking during pregnancy cannot be emphasised enough. Therefore, we put our effort to enhance SCC for pregnant Indigenous Australian women to support them to quit smoking for themselves and their families. Our research shows that smoking by Indigenous people is often influenced by numerous contextual, immediate social surroundings and personal factors, requiring SCC to be orchestrated at multiple levels and to be comprehensive. This presentation will be from Associate Prof Gillian Gould and members of her team to present their research on multiple aspects for interventions to address some of the major barriers around SCC. Ms Tabassum Rahman will present her systematic review about how the socio-ecological model can be applied to the barriers and enablers on system, health service, community and individual levels for the topic. A/Prof Gould will present the phased development and trials about the SISTAQUIT intervention (formerly ICAN QUIT in Pregnancy) that included an online training package for health professionals providing care to pregnant and postnatal Indigenous women, patient resources and free oral nicotine replacement therapy (NRT). A successful pilot study led to the randomised controlled trial of SISTAQUIT (Supporting Indigenous Smokers To Assist Quitting) and a national roll-out of the SCC care package as iSISTAQUIT, accompanied by a social media campaign. Dr Pari Eftekhari will present her research plan to engage family members, especially partners, in smoking cessation in pregnancy. Her research will explore partners perspectives to smoking cessation in pregnancy through our qualitative research project PAPAS. We will further outline a promising individual and community-based approach using the new MAMA-Empower Health App. Our collective goal is to make smoking cessation easier, more effective and relevant for Indigenous Australian women. The team will outline ways that the ASCP SIG could become involved in this research.

Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_H6BJDA5DSxye_lUJ40BFuw

After registering, you will receive a confirmation email containing information about joining the webinar

PRESENTERS

Gillian
 
Associate Professor Gillian Gould PhD, MBChB, MA (Arts Therapy), Dip Drama.

https://www.newcastle.edu.au/profile/gillian-gould

Associate Professor Gould is a GP and Tobacco Treatment Specialist with a wealth of clinical experience assisting smokers to quit. Her research focus is to improve the risks from tobacco smoking among Indigenous Australians.  She co-developed, over a decade, strategies to tackle smoking with Aboriginal communities, and led a regional Indigenous Tobacco Control Initiative (2010-12). Gould is an NHMRC Translating Research into Practice Fellow co-funded by Cancer Institute NSW, at University of Newcastle (UON). The fellowship will improve strategies for pregnant Indigenous smokers. Gould supervises 4 high-caliber PhD students at UON, and leads a multi-disciplinary team for the national SISTAQUIT (Supporting Indigenous Smokers To Assist Quitting) research project and the implementation phase of iSISTAQUIT. Other projects include co-developing the multi-behaviour change MAMA-EMPOWER App for a healthy Indigenous pregnancy.

Gould was awarded a career total of $12M in funding and has 54 peer-reviewed journal articles. Her contribution to Indigenous research is recognised by multiple awards: National Lead Clinicians Excellence Award for Indigenous Cultural Competence (2014), RACGP Indigenous Health Awards (2008, 2014) and Faculty of Aboriginal & Torres Strait Islander Health ‘Standing Strong Together Award’ (2009), Alan Chancellor Award (2016), Hunter Children’s Research Foundation Excellence Award (2016), HMRI ECR award (2017), APSAD Early Career Researcher Award (2018), Cure Cancer Australia Researcher of the Year (runner up 2018, 2019 and 2020). She was awarded International Visiting Research Fellowships to visit the Mayo Clinic, USA in 2017, and in 2018 to visit Maori colleagues in New Zealand. Gould is co-chair of the Lung Diseases Group for the Global Alliance for Chronic Disease.
 Tabassum Rahman UON
Tabassum Rahman, PhD Candidate (Public Health and Behavioural Science), MSS (Sociology), MDVST (Development Studies)  

Tabassum Rahman is doing her PhD research on Indigenous Australian women’s smoking and quitting behaviour, including smoking relapse in the context of pregnancy and postpartum to inform culturally appropriate smoking cessation interventions for Indigenous Australian women. Tabassum has experience of working in the field of violence against women, and with Indigenous communities overseas.

In her first year of PhD, along with A/Prof Gillian Gould, Tabassum won a Royal Australian College of General Practitioners (RACGP) Foundation grant to fund her research on smoking relapse among Indigenous Australian women. Tabassum also received the Stillbirth Centre for Research Excellence top-up PhD scholarship 2019 shortly after starting her PhD.
 Ally Hart
Allison Hart, Aboriginal Research Assistant and Cultural Liaison Officer Isistaquit

I am a Aboriginal woman local to the Coffs Harbour area, that is a descendant from the Aboriginal tribe Gumbaynggirr. I have worked within the Aboriginal communities both local and surrounding. I had previously worked as a Early Intervention Caseworker with Aboriginal mums in the Coffs Harbour area. Working with Aboriginal families (primarily Aboriginal Mothers) assisting, supporting and helping tackle issues including social, drug, alcohol and family wellbeing.

Working with ISISTAQUIT has allowed me to continue working with Aboriginal and Torres Strait Islander mums to help increase smoking cessation with Aboriginal mothers, by providing training information and resources for healthcare providers at Aboriginal Medical Services and mainstream services in the delivery of culturally competent evidence-based smoking cessation care.

 Parivash Eftekhari

Dr Parivash Eftekhari, PhD (Human Physiology and Epidemiology), PharmD

Dr Parivash Eftekhari is a postdoctoral researcher with the University of Newcastle. She is a doctor of pharmacy and she has completed two PhDs. Her current research is focused on novel and culturally tailored approaches for Indigenous people to improve children’s health. Dr Eftekhari benefits from her education in Epidemiology, and Gender and Health in leading her research project on partner support in smoking cessation during pregnancy for Indigenous people. This research highlights men’s attitude and readiness towards quitting smoking and providing support for their pregnant partners. This is a unique area of opportunity to improve Indigenous health.

 

Managing comorbidity - Tips and tricks for adapting practice in a changing environment

The Network of Alcohol and other Drugs Agencies (NADA) Webinar:
Managing comorbidity - Tips and tricks for adapting practice in a changing environment
 

21 May 2020, 12:00 – 1:00pm

Mental health and substance use issues frequently co-occur in substance use treatment settings. This webinar will provide a brief summary of comorbidity research, along with practical strategies to address comorbid mental health and substance use issues during the COVID-19 pandemic. This will include discussion of diversifying treatment and contact approaches, along with strategies for assessing and managing risk issues. Join Logan Harvey (clinical psychologist with the Matilda Centre) to explore these issues and answer questions you may have. 

Register now

 

Revised Insight - APSAD Webinar Program ready to roll

Insight Banner
Following our recent hiatus we're pleased to announce that our Insight-APSAD Webinars are all set to recommence this coming Wednesday 13th May at 10:00m AEST.

Here are the first three presentations to kick off Semester 1 - Vers 2.0: https://insight.qld.edu.au/training/webinars

WED. 13 MAY 2020, 10:00 AM
Dr Nikola Ognyenovits & co-presenter "Jasen"
Ibogaine: A solution or a false promise? WEBINAR

WED. 20 MAY 2020, 10:00 AM
Dr. Jeremy Hayllar
Another milestone for MATOD? The use of long acting injectable buprenorphine preparations in the treatment of opioid use disorder. WEBINAR

WED. 27 MAY 2020, 10:00 AM
Michelle Taylor
New Toolkits for Trauma Informed Care & Sensory Approaches WEBINAR

 

 

Webinar: The Utilisation, Effectiveness & Safety of Smoking Cessation Pharmacotherapies During Pregnancy: An Australian Population-Based Study

ASCP banner

POSTPONED: The Utilisation, Effectiveness and Safety of Smoking Cessation Pharmacotherapies During Pregnancy: An Australian Population-Based Study

Please note this webinar scheduled for the 31 March has now been postponed, the new date will be announced shortly. 

Presenter: Alys Havard, Senior Research Fellow, Centre for Big Data Research in Health, University of New South Wales

This NHMRC-funded research used linked pharmaceutical claims and administrative health data for all women who gave birth in New South Wales and Western Australia between 2004 and 2012 to examine the extent to which prescription NRT patches, bupropion and varenicline are used during pregnancy. To examine the effectiveness of these medicines during pregnancy, the smoking cessation rates associated with varenicline relative to NRT patch use was measured. The risk and benefits associated with these medicines in pregnancy was assessed by comparing the rate of adverse birth outcomes among women who used prescription NRT patches, bupropion or varenicline with the rate among women who smoked but did not receive any of these medicines.

 

POSTPONED: APSAD 2020 Brisbane Conference

POSTPONED TO 7-10 NOVEMBER 2021

APSAD 2021 750x300px

 

APSAD is following the ongoing developments on COVID-19 closely, with our priority being the safety and wellbeing of members, delegates, stakeholders, and our community. We appreciate the additional strain being felt by the AOD sector at all levels and, given the ongoing developments, APSAD Council has made the decision to postpone the 40th APSAD Brisbane Conference that was scheduled for 15-18 November 2020 in Brisbane.

Following consultation and review, we have decided on a postponement for 12 months to 7-10 November 2021 in Brisbane at the same venue, the Sofitel Brisbane Central. It was felt that late 2021 will be an ideal time for the sector to meet and collaborate as it adjusts to, and reviews the longer-term impact of COVID-19 on healthcare providers and consumers.

Registered delegates will be contacted directly. We strongly encourage you to transfer your registration to the new dates, however, registrations will be refunded with no penalty. Requests must be received in writing to This email address is being protected from spambots. You need JavaScript enabled to view it.

We’re immensely grateful to everyone who has contributed to APSAD conferences in the past 40 years and welcome your involvement on many more to come.

Thank you for your understanding and we look forward to seeing you in Brisbane in 2021.

 

 

Subcategories